A Randomized, Double-blind, Placebo-controlled, Multi-center. Cross-over Study of Rosuvastatin in Children and Adolescents (aged 6 to <18 years) with Homozygous Familial Hypercholesterolemia (HoFH)
|Effective start/end date||5/1/14 → 4/30/17|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.